Log In
BCIQ
Print this Print this
 

TB-403 (formerly RG7334)

  Manage Alerts
Collapse Summary General Information
Company ThromboGenics N.V.
DescriptionHumanized mAb against placental growth factor (PGF; PlGF)
Molecular Target Placental growth factor (PGF) (PlGF)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I/II
Standard IndicationBrain cancer
Indication DetailsTreat glioblastoma multiforme (GBM); Treat medulloblastoma; Treat relapsed or refractory medulloblastoma
Regulatory Designation
PartnerBioInvent International AB;
Oncurious N.V.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

04/14/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today